4.5 Article

Gadolinium Complex of 125I/127I-RGD-DOTA Conjugate as a Tumor-Targeting SPECT/MR Bimodal Imaging Probe

期刊

ACS MEDICINAL CHEMISTRY LETTERS
卷 4, 期 2, 页码 216-219

出版社

AMER CHEMICAL SOC
DOI: 10.1021/ml3003499

关键词

dual modality; SPECT/MR; RGD peptide; small molecule; tumor targeting

资金

  1. Programs of Development Research Center of PET Application Technology & The Programs of Clinical Application Research of Radiopharmaceuticals in the National Nuclear Technology Program, ROK
  2. Nuclear R&D Program through the National Research Foundation of Korea (NRF) [2009-0081817, 2012013722]
  3. MEST, ROK
  4. KNU

向作者/读者索取更多资源

The work describes the synthesis and in vivo application of [Gd(L)(H2O)]center dot xH(2)O, where L is a (I-125/I-127-RGD)- DOTA conjugate, as a tumor-targeting SPECT/MR bimodal imaging probe. Here, (I-125/I-127-RGD)-DOTA signifies a cocktail mixture of radioisotopic (1a, L = I-125-RGD-DOTA) and natural (1b, L = I-127-RGD-DOTA) Gd complexes. The two complexes are chemically equivalent as revealed by HPLC, and their cocktail mixture exhibits the integrin-specific tumor enhancement, demonstrating that they constitute essentially a single bimodal imaging probe. Employment of a cocktail mixture thus proves to be a sole and practical approach to overcome the sensitivity difference problem between MRI and SPECT.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据